Mr. Brown joined the Cumberland Pharmaceuticals Board of Directors in September of 2022. He joined Adams and Reese law firm in 1994 and primarily represents privately held businesses and their owners. His experience includes the licensing of intellectual property, international commerce, mergers and acquisitions and estate planning matters. He also advises on the private placement of securities and the implementation of stock option plans for employees.

Mr. Brown is an experienced health care attorney, having represented specialty pharmaceutical companies conducting financings and licensing rights to specialized technology, a biotechnology company in a dispute over intellectual property rights, and a foreign medical device manufacturer developing domestic distribution arrangements.

His credits also include service on the board of directors of the parent company of Aegis Sciences Corporation since 2018 and of Brown-Forman Corporation, a New York Stock Exchange listed company, from 2006 until 2016.

He is a former director of Centerstone Mental Health Center, then the tenth largest behavioral health provider in the nation. He served as President of the Yale Club of Middle Tennessee and is a member of the Economic Club of Nashville. Mr. Brown holds a J.D. from Vanderbilt University Law School and a B.A. from Yale University.

The Board believes Mr. Brown’s significant legal knowledge and experience with a public listed company are critical as the Company continues to navigate the responsibilities associated with being a public company.